JAMP TEMAZEPAM DIN 02565803
Health Canada record
| Active ingredient(s) | TEMAZEPAM 15 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
| Class | Human |
| ATC | N05CD07 TEMAZEPAM |
| Original market date | |
| Current status date | 16-Feb-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TEMAZEPAM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02565811 | JAMP TEMAZEPAM | JAMP PHARMA CORPORATION | Capsule | TEMAZEPAM 30 MG | Approved |
| 00604461 | RESTORIL | AA PHARMA INC | Capsule | TEMAZEPAM 30 MG | Marketed |
| 00604453 | RESTORIL | AA PHARMA INC | Capsule | TEMAZEPAM 15 MG | Marketed |
| 02223589 | TEMAZEPAM | APOTEX INC | Capsule | TEMAZEPAM 30 MG | Approved |
| 02223570 | TEMAZEPAM | APOTEX INC | Capsule | TEMAZEPAM 15 MG | Approved |
| 02225972 | APO-TEMAZEPAM | APOTEX INC | Capsule | TEMAZEPAM 30 MG | Dormant |
| 02225964 | APO-TEMAZEPAM | APOTEX INC | Capsule | TEMAZEPAM 15 MG | Dormant |
| 02244814 | CO TEMAZEPAM CAPSULES 15MG | COBALT PHARMACEUTICALS COMPANY | Capsule | TEMAZEPAM 15 MG | Cancelled Post Market |
| 02244815 | CO TEMAZEPAM CAPSULES 30MG | COBALT PHARMACEUTICALS COMPANY | Capsule | TEMAZEPAM 30 MG | Cancelled Post Market |
| 02229756 | DOM-TEMAZEPAM | DOMINION PHARMACAL | Capsule | TEMAZEPAM 15 MG | Cancelled Post Market |
| 02229758 | DOM-TEMAZEPAM | DOMINION PHARMACAL | Capsule | TEMAZEPAM 30 MG | Cancelled Post Market |
| 02231615 | GEN-TEMAZEPAM 15MG | GENPHARM ULC | Capsule | TEMAZEPAM 15 MG | Cancelled Post Market |
| 02231616 | GEN-TEMAZEPAM 30MG | GENPHARM ULC | Capsule | TEMAZEPAM 30 MG | Cancelled Post Market |
| 02347873 | NTP-TEMAZEPAM | NT PHARMA CANADA LTD | Capsule | TEMAZEPAM 30 MG | Cancelled Pre Market |
| 02347865 | NTP-TEMAZEPAM | NT PHARMA CANADA LTD | Capsule | TEMAZEPAM 15 MG | Cancelled Pre Market |
| 02239071 | PENTA-TEMAZEPAM CAPSULES | PENTAPHARM LTD. | Capsule | TEMAZEPAM 15 MG | Cancelled (Unreturned Annual) |
| 02239072 | PENTA-TEMAZEPAM CAPSULES | PENTAPHARM LTD. | Capsule | TEMAZEPAM 30 MG | Cancelled (Unreturned Annual) |
| 02297957 | PHL-TEMAZEPAM | PHARMEL INC | Capsule | TEMAZEPAM 15 MG | Cancelled Post Market |
| 02297965 | PHL-TEMAZEPAM | PHARMEL INC | Capsule | TEMAZEPAM 30 MG | Cancelled Post Market |
| 02273047 | PMS-TEMAZEPAM | PHARMASCIENCE INC | Capsule | TEMAZEPAM 30 MG | Dormant |
| 02273039 | PMS-TEMAZEPAM | PHARMASCIENCE INC | Capsule | TEMAZEPAM 15 MG | Dormant |
| 02229455 | PMS-TEMAZEPAM - 15MG | PHARMASCIENCE INC | Capsule | TEMAZEPAM 15 MG | Cancelled Post Market |
| 02229456 | PMS-TEMAZEPAM - 30MG | PHARMASCIENCE INC | Capsule | TEMAZEPAM 30 MG | Cancelled Post Market |
| 02243024 | RATIO-TEMAZEPAM | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Capsule | TEMAZEPAM 30 MG | Cancelled Post Market |
| 02243023 | RATIO-TEMAZEPAM | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Capsule | TEMAZEPAM 15 MG | Cancelled Post Market |
| 02229760 | TEMAZEPAM-15 | PRO DOC LIMITEE | Capsule | TEMAZEPAM 15 MG | Cancelled Post Market |
| 02229761 | TEMAZEPAM-30 | PRO DOC LIMITEE | Capsule | TEMAZEPAM 30 MG | Cancelled Post Market |
| 02230102 | TEVA-TEMAZEPAM | TEVA CANADA LIMITED | Capsule | TEMAZEPAM 30 MG | Cancelled Post Market |
| 02230095 | TEVA-TEMAZEPAM | TEVA CANADA LIMITED | Capsule | TEMAZEPAM 15 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36908 | 2026-02-16 | Abbreviated New Drug Submission (ANDS) |
International API supply for TEMAZEPAM
1 valid EDQM Certificates of Suitability from 1 holders. 5 active FDA Drug Master Files.
Request a quote for JAMP TEMAZEPAM